OVERVIEW
Trusted vessel sealing technology1 meets next-level performance.2,†,‡
The LigaSure™ XP Maryland jaw sealer/divider is advancing surgical energy to meet the evolving needs of surgeons and their patients.
With the LigaSure™ XP Maryland jaw device, you get all the advantages of the LigaSure™ technology you’ve come to love, plus additional next-level benefits:
- The confidence to reliably seal thick tissue3,4,§,||
- Precise sealing,5,¶ cutting, and dissection3,#,†† at the tip of longer Maryland jaws6,‡‡,§§
- Continuous 360° jaw rotation boosts procedural efficiency through undisrupted movement3,||,††
- Nano-coating performance consistent with legacy LigaSure™ devices,3,7,|| resulting in reduced tissue sticking compared to competing devices7,||||
Get ready to experience next-level performance, precision, and procedural efficiency2,†,‡,¶¶ with the LigaSure™ XP Maryland jaw device.
AN ELEVATED LEVEL OF DEVICE PRECISION1,†,‡
- Curved, tapered jaws enable fine dissection and skeletonization of vessels3,Ω
- Provides sealing5,§§ and more precise cutting3,ΩΩ at the tip of the jaws
- Jaw design makes it easier to access tissue planes or create windows3,‡‡,ΩΩ
NEXT-LEVEL PERFORMANCE, PRECISION, AND PROCEDURAL EFFICIENCY2,†,‡,¶¶
Take a deeper dive into the vessel sealing and dissection advantages of the LigaSure™ XP Maryland jaw device.
SEE THE DIFFERENCE OF A LONGER JAW
1. 3.1 mm longer6,§§
2. Vessel sealing5,¶ and cutting3,#,†† to the tips of the jaws
A. LigaSure™ Maryland jaw
B. LigaSure™ XP Maryland jaw
VESSEL SEALING AND DISSECTION THAT OUTPERFORMS THE COMPETITION
Compared to the Ethicon Enseal™* X1 device, the LigaSure™ XP Maryland jaw device provides:
- Greater average burst pressure on isolated large vessels (5.1–7.0 mm)8,||||
- Higher average burst pressure in thick tissue4,§,||||
- A finer jaw6,## that grasps6,††† and transects6,‡‡‡ more tissue per bite while cutting closer to the device tip6,§§§
- † The LigaSure™ XP Maryland jaw device is indicated for use in general surgery and such surgical specialties as colorectal, bariatric, urologic, vascular, thoracic, and gynecologic.
- ‡ Compared to their current preferred device; 21 of 23 surgeons agreed during clinical procedures.
- § Thick tissue is defined as nondissected vascular tissue or fatty tissue.
- || 29 out of 29 surgeons agree.
- ¶ 30 out of 30 surgeons agree.
- # 24 out of 29 surgeons agree.
- †† Compared to legacy LigaSure™ devices.
- ‡‡ LigaSure™ XP Maryland seal plate length (22.555 mm) vs. LigaSure™ Maryland seal plate length (19.406 mm) as measured from seal plate tip to device tissue stop.
- §§ LigaSure™ XP Maryland cut length (21.844 mm) vs. LigaSure™ Maryland cut length (18.034 mm).
- |||| Bench tissue may not be indicative of clinical performance.
- ¶¶ Compared to their current preferred device; 20 of 23 surgeons agreed during clinical procedures.
- ##LigaSure™ XP Maryland jaw width by height (1.47 mm by 2.13 mm) vs. Ethicon Enseal™* X1 width by height (1.57 mm by 2.90 mm).
- †††LigaSure™ XP Maryland jaw length & aperture (23.368 mm & 14.437 mm) vs. Ethicon Enseal™* X1 jaw length & aperture (22.682 mm & 13.462 mm) as measured from device tip to tissue stop.
- ‡‡‡LigaSure™ XP Maryland cut length (21.844 mm) vs. Ethicon Enseal™* X1 cut length (21.133 mm).
- §§§LigaSure™ XP Maryland uncut seal length on seal plate (1.143 mm) vs. Ethicon Enseal™* X1 uncut seal length on seal plate (1.727 mm).
- 1. Based on COGNOS and historical sales data, FY01–FY20. October 2019.
- 2. Based on internal report #RE00457416 Rev A, Product introduction report: LigaSure™ XP Maryland jaw sealer/divider. May 2023.
- 3. Based on internal report #RE00376094 Rev A, LigaSure™ XP Maryland jaw sealer/divider surgeon validation marketing report. Dec. 7–9 and 14–16, 2021.
- 4. Based on internal report #RE00442444 Rev A, Comparison of the renal artery bench bundle burst pressure performance with the LigaSure™ XP Maryland jaw sealer/divider, Voyant™* Maryland Fusion, Enseal™* X1 curved jaw, and LigaSure™ LF19XX devices. Jan. 23, 2023.
- 5. Based on internal report #RE00372649 Rev A, Archer surgeon summative evaluation report. March 22, 2022.
- 6. Based on internal test report #RE00455509 Rev B, Competitive device analysis — LigaSure™ XP Maryland jaw sealer/divider.
- 7. Based on internal report #RE00380835 Rev B, Sticking evaluation with the LigaSure™ XP Maryland jaw sealer/divider, Aesculap Caiman™* 5 Maryland, Voyant™* Maryland Fusion, Ethicon Enseal™* X1 curved jaw, LigaSure™ LF18XX blunt tip, and LF19XX Maryland devices.
- 8. Based on internal report #RE00380822 Rev A, Comparison of the renal artery seal burst pressure performance with the LigaSure™ XP Maryland jaw sealer/divider, Caiman™* 5 Maryland, Voyant™* Maryland Fusion, Enseal™* X1 curved jaw, Sonicision™ 7 curved jaw, Harmonic™* 1100, LigaSure™ LF18XX, and LF19XX devices.